Collagen and proteoglycan abnormalities in the GDF-5-deficient mice and molecular changes when treating disk cells with recombinant growth factor.
about
Regeneration of intervertebral disc by mesenchymal stem cells: potentials, limitations, and future directionDisc in flames: Roles of TNF-α and IL-1β in intervertebral disc degenerationChallenges and strategies in the repair of ruptured annulus fibrosusEmerging technologies for molecular therapy for intervertebral disk degenerationStem cell therapy for degenerative disc diseaseAnimal models for disc degeneration-an update.Fullerol nanoparticles suppress inflammatory response and adipogenesis of vertebral bone marrow stromal cells--a potential novel treatment for intervertebral disc degeneration.Annulus fibrosus cell characteristics are a potential source of intervertebral disc pathogenesis.The challenge and advancement of annulus fibrosus tissue engineering.A modified aggregate culture for chondrogenesis of human adipose-derived stem cells genetically modified with growth and differentiation factor 5Therapeutic effects of adenovirus-mediated growth and differentiation factor-5 in a mice disc degeneration model induced by annulus needle puncture.Nucleus pulposus tissue engineering: a brief reviewBiomechanical Conditioning Enhanced Matrix Synthesis in Nucleus Pulposus Cells Cultured in Agarose Constructs with TGFβNuclei pulposi formation from the embryonic notochord occurs normally in GDF-5-deficient mice.Growth factors and anticatabolic substances for prevention and management of intervertebral disc degeneration.Adenovirus-mediated GDF-5 promotes the extracellular matrix expression in degenerative nucleus pulposus cells.Prevention of disc degeneration with growth factors.Pharmacological enhancement of disc diffusion and differentiation of healthy, ageing and degenerated discs : Results from in-vivo serial post-contrast MRI studies in 365 human lumbar discsDisruption of the thrombospondin-2 gene alters the lamellar morphology but does not permit vascularization of the adult mouse lumbar disc.Biological repair of the degenerated intervertebral disc by the injection of growth factors.Inhibition of microRNA-34a prevents IL-1β-induced extracellular matrix degradation in nucleus pulposus by increasing GDF5 expression.Expression of cartilage-derived morphogenetic protein in human intervertebral discs and its effect on matrix synthesis in degenerate human nucleus pulposus cells.Intervertebral disc regeneration: from the degenerative cascade to molecular therapy and tissue engineering.Molecular and genetic advances in the regeneration of the intervertebral disc.Biologic treatment of mild and moderate intervertebral disc degeneration.Growth factors and platelet-rich plasma: promising biological strategies for early intervertebral disc degeneration.Signaling networks in joint development.Co-culture induces mesenchymal stem cell differentiation and modulation of the degenerate human nucleus pulposus cell phenotype.Potential of co-culture of nucleus pulposus mesenchymal stem cells and nucleus pulposus cells in hyperosmotic microenvironment for intervertebral disc regeneration.Impact of direct cell co-cultures on human adipose-derived stromal cells and nucleus pulposus cells.Characterization of the early molecular changes in the glomeruli of Cd151 -/- mice highlights induction of mindin and MMP-10.TGF-β1 and GDF5 Act Synergistically to Drive the Differentiation of Human Adipose Stromal Cells toward Nucleus Pulposus-like Cells.Effects of releasing recombinant human growth and differentiation factor-5 from poly(lactic-co-glycolic acid) microspheres for repair of the rat degenerated intervertebral disc.Treatment with rhBMP12 or rhBMP13 increase the rate and the quality of rat Achilles tendon repair.Overexpression of growth and differentiation factor-5 inhibits inflammatory factors released by intervertebral disc cells.Association between GDF5 rs143383 genetic polymorphism and musculoskeletal degenerative diseases susceptibility: a meta-analysis
P2860
Q24657707-3D53C9DD-8049-4634-B07A-49E5ADC237AEQ26783031-5E9FE381-907B-4619-8FC5-388F2FEF405EQ26829807-927C30B3-0E57-4E15-B037-57968544973BQ27693848-D5D9052E-805D-4251-84B5-F359CAEC0CADQ28384160-4424AE13-802C-44AB-B8BD-613D427E283DQ30252208-06EBB592-9318-4D01-AC58-88F58FE300B5Q30409893-085DE558-17A6-413A-A244-7212D4A41F2EQ30413145-A770D285-AEB3-4AFB-B26F-B1778B3A7E53Q30413330-2F84EA67-56E5-439C-B3EB-300035A99D07Q30417785-B56FFFC9-CBAB-43B4-8CE1-C1D198F4E28BQ30433732-40EC8E61-63ED-47A3-A73A-0A15A08CF459Q30434295-8BC3FDC4-461B-42C8-B046-84BB163AF531Q33649899-0A13C29E-F339-4A1C-910F-A070C3C66D9EQ35022188-D60550B2-B76E-4686-B2C2-F7767894C849Q35550872-A39C4168-AEC0-4F8B-BD54-1A7329BA6994Q36456967-C20B6A43-774F-4386-A2AB-D279B3DA091BQ36545845-CCB981E3-D320-4CED-9934-9DC6A49026A9Q36632647-28F137C8-84FB-48AE-9EF4-1A64961E27BBQ36955323-7132590F-BEC3-44AC-94A6-3F134EA284C3Q37324308-B2A3647B-1E0F-4DED-BD32-A40A2120432AQ37347213-462F07F1-341D-44AF-9504-E0D30D1A7BF6Q37454079-6F6DF9D6-971C-4BCD-B964-3255C76A7E22Q38091404-0FB8CB9F-7B07-435A-AC0E-A63CA849DD60Q38104354-DC560D61-1480-476A-8139-603EEFD142A4Q38244571-B29ACAD2-59D6-4A21-A680-C74791B15371Q38344714-F1A446DD-CF1A-45EE-A3E1-360C8F36C808Q39012411-E050370B-CC18-44FD-90A2-9547175B7540Q43500600-B6421DC7-8C3C-4589-8C55-4E3BC8AB7EFEQ44558569-2C81671E-9252-4EB3-BE6F-7348A53BE3C4Q46801671-9C23812A-B639-491C-B239-616E73114DC5Q47096963-CBDBAABA-ED92-46C9-9D55-87A9C3E4B30FQ47609492-8D351CE3-27A1-40EA-BFC1-65A1E0EA0010Q51767489-E2847E53-C506-4AD7-9CF5-9382C38C2F5AQ53430424-9A1544CB-E35E-4BF7-9D27-1F11864BBDFCQ55340149-C7EB746A-69DE-4FC3-BE2A-6E3A9A87CB09Q58741835-ADB65396-3147-46C6-8B8D-E7948E3F12A5
P2860
Collagen and proteoglycan abnormalities in the GDF-5-deficient mice and molecular changes when treating disk cells with recombinant growth factor.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Collagen and proteoglycan abno ...... ith recombinant growth factor.
@ast
Collagen and proteoglycan abno ...... ith recombinant growth factor.
@en
type
label
Collagen and proteoglycan abno ...... ith recombinant growth factor.
@ast
Collagen and proteoglycan abno ...... ith recombinant growth factor.
@en
prefLabel
Collagen and proteoglycan abno ...... ith recombinant growth factor.
@ast
Collagen and proteoglycan abno ...... ith recombinant growth factor.
@en
P2093
P1433
P1476
Collagen and proteoglycan abno ...... ith recombinant growth factor.
@en
P2093
Brian M Leo
Gary Balian
Greg D Anderson
P304
P356
10.1097/01.BRS.0000142427.82605.FB
P407
P577
2004-10-01T00:00:00Z